pharmacodynamic modeling showed that there were no significant differences between healthy subjects and patients with chf in either er50 ( bumetanide urinary excretion rate producing 50 % of maximum drug effect ) or s ( slope ) , although the baseline effect was 15 times lower in chf .
C0006376
bumetanide
C0018802
chf